Skip to main content
. 2021 Sep 30;12(3):1054–1067. doi: 10.1016/j.apsb.2021.09.028

Figure 4.

Figure 4

Potential therapeutic targets and drugs for the treatment of ESCC and EAC. Drugs in red have been approved by FDA, drugs in black are at different stages of clinical trials, while drugs in blue are in preclinical studies.